trial summary · NCT07897344
Short-Term Reduced Dietary Protein in ER+/HER2- Breast Cancer Patients During Neoadjuvant Chemotherapy
A Pilot Trial of Controlled Feeding With Reduced Dietary Protein in Patients With Estrogen Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer Receiving Neoadjuvant Chemotherapy
Trial record from the TrialBase DB dataset, status RECRUITING, condition Breast Cancer, sponsored by Josephine Connolly-Schoonen. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
This study will examine if a short-term, reduced protein diet for the 3-day period prior to and on the day of each of the first 4 chemotherapy cycles and 4 days prior to primary breast surgery is well tolerated and adhered to by patients with stage II or III estrogen receptor positive (ER+) human epidermal growth factor receptor negative (HER2-) breast cancer (BC) receiving neoadjuvant chemotherapy (NAC).
Source record: https://clinicaltrials.gov/study/NCT07897344
Facts
| registry id | NCT07897344 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | not reported |
| study type | INTERVENTIONAL |
| lead condition | Breast Cancer |
| sponsor | Josephine Connolly-Schoonen |
| sponsor class | OTHER |
| enrollment | 15 |
| start date | 2026-11-02 |
| primary completion | 2028-10-30 |
| completion | 2029-04-30 |
| results posted | not reported |
Conditions
- Breast Cancer
- Hormone Receptor Positive / HER2-negative Breast Cancer
Interventions
- Dietary Protein Intervention
Countries
- United States
Intervention types: OTHER
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.